NO20034873L - Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering - Google Patents
Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avleveringInfo
- Publication number
- NO20034873L NO20034873L NO20034873A NO20034873A NO20034873L NO 20034873 L NO20034873 L NO 20034873L NO 20034873 A NO20034873 A NO 20034873A NO 20034873 A NO20034873 A NO 20034873A NO 20034873 L NO20034873 L NO 20034873L
- Authority
- NO
- Norway
- Prior art keywords
- dihydroxy
- derivatives
- stratriene
- degree
- formulations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02004787A EP1340503A1 (en) | 2002-03-01 | 2002-03-01 | Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery |
PCT/EP2003/001856 WO2003074058A1 (en) | 2002-03-01 | 2003-02-24 | Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20034873D0 NO20034873D0 (no) | 2003-10-31 |
NO20034873L true NO20034873L (no) | 2003-12-23 |
Family
ID=27675680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20034873A NO20034873L (no) | 2002-03-01 | 2003-10-31 | Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050209207A1 (no) |
EP (2) | EP1340503A1 (no) |
AT (1) | ATE381339T1 (no) |
AU (1) | AU2003215588A1 (no) |
BR (1) | BR0303347A (no) |
DE (1) | DE60318182T2 (no) |
ES (1) | ES2297183T3 (no) |
NO (1) | NO20034873L (no) |
WO (1) | WO2003074058A1 (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP1100723A2 (en) * | 2011-12-28 | 2013-06-28 | Avidin Kft | Use of estrogen derivatives for preparing medicament for the treatment of psychiatric diseases |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1099722A (en) * | 1964-04-20 | 1968-01-17 | Takeda Chemical Industries Ltd | Aerosol |
DE2758549A1 (de) * | 1977-12-23 | 1979-07-05 | Schering Ag | Pharmazeutische zubereitung |
US4315925A (en) * | 1980-05-30 | 1982-02-16 | University Of Kentucky Research Foundation | Method of administering natural female sex hormones |
US5043331A (en) * | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
WO1992006675A1 (en) * | 1990-10-18 | 1992-04-30 | Minnesota Mining And Manufacturing Company | Aerosol formulation comprising beclomethasone 17,21 dipropionate |
WO1998034595A1 (de) * | 1997-02-05 | 1998-08-13 | Jago Research Ag | Medizinische aerosolformulierungen |
US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
GB2326334A (en) * | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
EP1027057A4 (en) * | 1997-10-28 | 2003-01-02 | Vivus Inc | TREATMENT OF FEMALE SEXUAL DISORDERS |
IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
-
2002
- 2002-03-01 EP EP02004787A patent/EP1340503A1/en not_active Withdrawn
-
2003
- 2003-02-24 US US10/504,841 patent/US20050209207A1/en not_active Abandoned
- 2003-02-24 AT AT03743324T patent/ATE381339T1/de active
- 2003-02-24 BR BR0303347-3A patent/BR0303347A/pt not_active IP Right Cessation
- 2003-02-24 WO PCT/EP2003/001856 patent/WO2003074058A1/en active IP Right Grant
- 2003-02-24 DE DE60318182T patent/DE60318182T2/de not_active Expired - Lifetime
- 2003-02-24 EP EP03743324A patent/EP1480651B1/en not_active Expired - Lifetime
- 2003-02-24 AU AU2003215588A patent/AU2003215588A1/en not_active Abandoned
- 2003-02-24 ES ES03743324T patent/ES2297183T3/es not_active Expired - Lifetime
- 2003-10-31 NO NO20034873A patent/NO20034873L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE381339T1 (de) | 2008-01-15 |
DE60318182D1 (de) | 2008-01-31 |
US20050209207A1 (en) | 2005-09-22 |
DE60318182T2 (de) | 2008-12-04 |
BR0303347A (pt) | 2004-07-13 |
EP1340503A1 (en) | 2003-09-03 |
AU2003215588A1 (en) | 2003-09-16 |
WO2003074058A1 (en) | 2003-09-12 |
NO20034873D0 (no) | 2003-10-31 |
ES2297183T3 (es) | 2008-05-01 |
EP1480651B1 (en) | 2007-12-19 |
EP1480651A1 (en) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO2381B1 (en) | Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease | |
CY1122851T1 (el) | Υπερλεπτο σκευασμα φορμοτερολης | |
DK1389137T3 (da) | Sammensætninger til lungelægemiddellevering af protein | |
HUP0202311A2 (hu) | Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében | |
DE69205177D1 (de) | Pharmazeutische Aerosolformulierung. | |
DK0656207T4 (da) | Aerosolformuleringer uden chlorfluorcarbonforbindelser | |
BR9915095A (pt) | Composição farmacêutica ministrável em aerosol | |
PT918507E (pt) | Formulacoes em aerossol | |
YU59899A (sh) | Medicinski aerosolni proizvodi | |
CO4940408A1 (es) | Composicion de aerosol farmaceutico | |
SE0102276D0 (sv) | Device and method for the administration of a medicament | |
GB0323684D0 (en) | Improvements in or relating to organic compounds | |
IT1317720B1 (it) | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. | |
BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
AR002027A1 (es) | Formulaciones transdermicas y proceso para prepararlas. | |
NO20034873L (no) | Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering | |
DE60017450D1 (de) | Pharmazeutische formulierungen enthaltend salmeterol | |
BR0209578A (pt) | Uso de um gatran ou de um derivado farmaceuticamente aceitável do mesmo, método de tratamento de fibrose pulmonar, e, formulação farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |